Long-Term Outcome in Patients With Heart Failure Treated With Levothyroxine: An Observational Nationwide Cohort Study | Zendy

Mette Nygaard Einfeldt | Zendy; AnneMarie Schjerning Olsen | Zendy; Søren Lund Kristensen | Zendy; Usman Khalid | Zendy; Jens Faber | Zendy; Christian TorpPedersen | Zendy; Gunnar Gislason | Zendy; Christian Selmer | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Long-Term Outcome in Patients With Heart Failure Treated With Levothyroxine: An Observational Nationwide Cohort Study

Author(s) -

Mette Nygaard Einfeldt,

AnneMarie Schjerning Olsen,

Søren Lund Kristensen,

Usman Khalid,

Jens Faber,

Christian TorpPedersen,

Gunnar Gislason,

Christian Selmer

Publication year - 2018

Publication title -

the journal of clinical endocrinology and metabolism

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.206

H-Index - 353

eISSN - 1945-7197

pISSN - 0021-972X

DOI - 10.1210/jc.2018-01604

Subject(s) - medicine , levothyroxine , mace , interquartile range , myocardial infarction , heart failure , retrospective cohort study , rate ratio , cohort study , hazard ratio , cohort , confidence interval , percutaneous coronary intervention , thyroid

Hypothyroidism has detrimental effects on the cardiovascular system, but controversy remains concerning the benefits of levothyroxine (L-T4) substitution in patients with heart failure (HF).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research